The largest database of trusted experimental protocols

Us mo 14 18947

US/MO/14-18947 is a laboratory equipment product. It is designed for use in scientific research and testing applications. The core function of this product is to facilitate specific tasks or procedures within a laboratory setting. However, a detailed description of its features and intended use cannot be provided while maintaining an unbiased and purely factual approach.

Automatically generated - may contain errors

6 protocols using us mo 14 18947

1

Culturing and Amplification of Enteroviruses

Check if the same lab product or an alternative is used in the 5 most similar protocols
Rhabdomyosarcoma (RD, ATCC, CCL-136), A172 (ATCC, CRL-1620) and SH-SY5Y (ATCC, CRL-2266) were maintained in a 37 °C incubator in a 5% CO2 atmosphere. RD cell was cultured in Dulbecco’s modified Eagle’s medium (DMEM) with 10% fetal bovine serum (FBS) and 1% penicillin-streptomycin (P/S). SH-SY5Y were cultured in 10% FBS and 1% P/S with 50% DMEM and 50% F-12 medium. All of the following EV-D68 strains used in this study were purchased from ATCC: US/KY/14-18953 (ATCC, NE-49132), US/MO/14-18947 (ATCC, NR-49129), US/MO/14-18949 (ATCC, NR-49130), US/IL/14-18952 (ATCC, NR-49131), US/IL/14-18956 (ATCC, NR-49133). All of the following EV-A71 strains used in this study were purchased from ATCC or BEI Resources: Tainan/4643/1998 (BEI Resources, NR-471), Enterovirus 71, MP4 (BEI Resources, NR-472). Enteroviruses A71 US/CT/2016- 19519 was obtained from Dr. William Nix at the Centers for Disease Control and Prevention under a material transfer agreement. All viruses were amplified in RD cells prior to infection assays.
+ Open protocol
+ Expand
2

Rhabdomyosarcoma and EV-D68 Virus Culture

Check if the same lab product or an alternative is used in the 5 most similar protocols
Rhabdomyosarcoma (RD, ATCC, CCL-136), A172 (ATCC, CRL-1620), A549 (ATCC,
CCL-185), HeLa (ATCC, CCL-2), and SH-SY5Y (ATCC, CRL-2266) were maintained in a
37 °C in a 5% CO2 atmosphere. RD and A172 were cultured in
Dulbecco’s modified Eagle’s medium (DMEM) with 10% fetal bovine
serum (FBS) and 1% penicillin-streptomycin (P/S). SH-SY5Y were cultured in 10%
FBS and 1% P/S with 50% DMEM and 50% F-12 medium. All of the following EV-D68
strains used in this study were purchased from ATCC: US/KY/14-18953 (ATCC,
NE-49132), US/MO/14-18947 (ATCC, NR-49129), US/MO/14-18949 (ATCC, NR-49130),
US/IL/14-18952 (ATCC, NR-49131), US/IL/14-18956 (ATCC, NR-49133).
+ Open protocol
+ Expand
3

Propagation and Maintenance of EV-D68 and EV-A71 Viruses

Check if the same lab product or an alternative is used in the 5 most similar protocols
The Fermon (ATCC, VR-1826), US/KY/14-18953 (ATCC, VR-1825D), and US/MO/14-18947 (ATCC, VR-1823D) strains of EV-D68; and the Changchun077 strain of EV-A71 have been reported previously (Wang et al., 2012 (link)). Viruses were propagated in human rhabdomyosarcoma RD cells (No CCL-136), and the supernatants were harvested and stored at −80°C. Human embryonic kidney cells (HEK 293T cells) (No CRL-11268) and RD cells were purchased from the ATCC (Manassas, VA, USA) and used according to a previous study (Wang et al., 2015 (link)). Cells were maintained in Dulbecco's modified Eagle's medium (DMEM) (Hyclone, Logan, UT, USA) supplemented with 10% fetal bovine serum (FBS) (GIBCO BRL, Grand Island, NY, USA).
+ Open protocol
+ Expand
4

Enterovirus Isolation and Purification Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
EV-D68 prototype Fermon (2014) isolated US/MO/14-18947 (MO) and US/KY/14-18953 (KY) were purchased from ATCC. Professor Cheng Tong kindly provided the EV-A71 prototype Anhui2007, and prototype CC063 was isolated in our laboratory. Viruses propagated in RD cells. The supernatants of enterovirus-infected cells were harvested, filtered through a 0.22 mm filter, and centrifuged through a 20% sucrose cushion in an SW28 rotor at 28,000 rpm for 1.5 h. Purified pellets were stored at −80°C.
+ Open protocol
+ Expand
5

Enterovirus D68 Strain Propagation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Three strains of enterovirus D68 were obtained: US/MO/14-18947 (purchased from BEI Resources, NR-49129, lot no. 63205984), US/IL/14-18952 (purchased from BEI Resources, NR-49131, lot no. 63205985), and EV-D68 Fermon strain (generous gift from Charles Y. Chiu at the University of California, San Francisco, CA). Enterovirus D68 strains were grown in human muscle rhabdomyosarcoma (RD) cells (purchased from ATCC CCL-136) for all experiments except those shown in Fig. 5, for which US/MO/14-18947 was grown in SH-SY5Y neuroblastoma cells (purchased from ATCC CRL-2266). Virus was added at a multiplicity of infection (MOI) of 100 to RD cells in a T182 flask for 60 min, followed by a phosphate-buffered saline (PBS) rinse and incubation in 10 mL medium (95% high-glucose Dulbecco’s modified eagle medium [DMEM] + 5% fetal bovine serum [FBS]) for 3 days at 33°C. All strains killed 99% of RD cells in the flask after 3 days.
+ Open protocol
+ Expand
6

Culturing RD and Vero Cells for Enterovirus Assays

Check if the same lab product or an alternative is used in the 5 most similar protocols
RD and Vero Cells were maintained in Dulbecco’s modified Eagle’s medium (DMEM) containing 10% fetal bovine serum (FBS) as described previously56 (link),57 (link). CV-A10 strains S0148b, S0273b, and Kowalik have been described in a previous study24 (link). EV-A71/G082 and CV-A16/SZ05 have been described previously54 (link). EV-D68 strains US/MO/14-18947 (ATCC Number: VR-1823), US/KY/14-18953 (VR-1825), and Fermon (VR-1826) were obtained from ATCC. CV-B3 strain Nancy and PV-1 strain Sabin have been described in a previous study58 (link). All virus stocks were made in RD cells. Virus titers were determined according to the Reed–Muench method59 and expressed as 50% tissue culture infectious dose (TCID50).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!